BRCA1/2 and CHEK2 Pathogenic Variants in Urological Cancers: A Portuguese Single-Center Experience
Cureus · 10.03.2026
DOI: 10.7759/cureus.105002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cureus, erschienen am 10.03.2026. Verfasst von Margarida Quinto Pereira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, PRT. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Oncology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, PRT.
- Molecular Pathobiology Research Unit, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, PRT.
- Familial Cancer Clinic Unit, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, PRT.
Zitieren
APA
Quinto Pereira, M., Miguel, I., Fragoso, S., Duarte, T., Santos, S., Rodrigues, P., Pereira, C., & Vaz, F. (2026). BRCA1/2 and CHEK2 Pathogenic Variants in Urological Cancers: A Portuguese Single-Center Experience. Cureus. https://doi.org/10.7759/cureus.105002
Vancouver
Quinto Pereira M, Miguel I, Fragoso S, Duarte T, Santos S, Rodrigues P, et al. BRCA1/2 and CHEK2 Pathogenic Variants in Urological Cancers: A Portuguese Single-Center Experience. Cureus. 2026. doi:10.7759/cureus.105002
BibTeX
@article{QuintoPereira2026,
author = {Quinto Pereira, Margarida and Miguel, Isália and Fragoso, Sofia and Duarte, Teresa and Santos, Sidónia and Rodrigues, Paula and Pereira, Carolina and Vaz, Fátima},
title = {BRCA1/2 and CHEK2 Pathogenic Variants in Urological Cancers: A Portuguese Single-Center Experience},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.105002}
}
EUVIMED